1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one manufacturers
- Emraclidine
-
- $2.00
-
2026-08-25
- CAS:2170722-84-4
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
- Emraclidine
-
-
2026-08-05
- CAS:2170722-84-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 1000kgs
- Emraclidine
-
- $129.00
-
2026-06-02
- CAS:2170722-84-4
- Purity: 99.63%
- Supply Ability: 10g
|
| | 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one Basic information |
| Product Name: | 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one | | Synonyms: | 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one;Emraclidine,muscarinic,Schizophrenia,Parkinson,Muscarinic acetylcholine receptor,CVL231,Inhibitor,positive,mAChR,Alzheimer,neurological,inhibit,CVL 231,allosteric;1-(2,4-dimethyl-5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-2-[1-[2-(trifluoromethyl)-4-pyridyl]azetidin-3-yl]ethanone;Ethanone, 1-(5,7-dihydro-2,4-dimethyl-6H-pyrrolo[3,4-b]pyridin-6-yl)-2-[1-[2-(trifluoromethyl)-4-pyridinyl]-3-azetidinyl]-;1-[2,4-Dimethyl-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl]-2-[1-[2-(trifluoromethyl)-4-pyridyl]azetidin-3-yl]ethanone;Emraclidine, 10 mM in DMSO;PF-06852231;1-(2,4-Dimethyl-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-2-(1-(2-(trifluoromethyl)pyridin-4-yl)azetidin-3-yl)ethan-1-one | | CAS: | 2170722-84-4 | | MF: | C20H21F3N4O | | MW: | 390.4 | | EINECS: | | | Product Categories: | | | Mol File: | 2170722-84-4.mol | ![1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one Structure](CAS/20210305/GIF/2170722-84-4.gif) |
| | 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one Chemical Properties |
| Boiling point | 546.7±50.0 °C(Predicted) | | density | 1.320±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 25 mg/mL (64.04 mM; Need ultrasonic) | | pka | 6.14±0.20(Predicted) | | form | Solid | | color | Off-white to light yellow | | InChI | InChI=1S/C20H21F3N4O/c1-12-5-13(2)25-17-11-27(10-16(12)17)19(28)6-14-8-26(9-14)15-3-4-24-18(7-15)20(21,22)23/h3-5,7,14H,6,8-11H2,1-2H3 | | InChIKey | DTCZNKWBDTXEBS-UHFFFAOYSA-N | | SMILES | C(=O)(N1CC2=C(C)C=C(C)N=C2C1)CC1CN(C2C=CN=C(C(F)(F)F)C=2)C1 |
| | 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one Usage And Synthesis |
| Uses | Emraclidine (CVL-231) is a muscarinic M4 receptor positive allosteric modulator (WO2018002760, compound 11). Emraclidine can be used for the research of neurological diseases[1]. | | References | [1] WO2018002760 |
| | 1-{2,4-dimethyl-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-y l}-2-{1-[2-(trifluoromethyl)pyridin-4-yl]azetidin-3-yl }ethan-1-one Preparation Products And Raw materials |
|